Hepatocellular carcinoma (HCC) occurs most frequently in men, with three-quarters of those cases expressing the androgen receptor, though its role in pathogenesis remains unclear. Here’s a thought-provoking case report of a peripubertal transgender male presenting with a 17.5 cm HCC following 14 months of weekly testosterone injections as part of his gender reassignment therapy. | Lin, Lancet 2020


Popular Posts